January 31, 2018
AIT Therapeutics acquires license to eNOGenerator from NitricGen for $2M plus milestones
AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients…